| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |